# Nucleic Acid Testing  to Reduce the Possible Risk of Parvovirus B19 Transmission by Plasma-Derived Products:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/nucleic-acid-testing-to-reduce-the-possible-risk-of-parvovirus-b19-transmission-by-plasma-derived-products-guidance-for-industry/61270a0b-4323-4d9d-8dab-c2b9ea3aaf2c

> FDA guidance document: Nucleic Acid Testing  to Reduce the Possible Risk of Parvovirus B19 Transmission by Plasma-Derived Products:  Guidance for Industry. Issue date: July 28, 2009. Get complete insights and analysis.

---

## Details

- Title: Nucleic Acid Testing  to Reduce the Possible Risk of Parvovirus B19 Transmission by Plasma-Derived Products:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2009-07-28
- Last Changed: 2019-05-15
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2008-D-0379">FDA-2008-D-0379</a>

## Related Documents

- [Clinical Considerations for Therapeutic Cancer Vaccines:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-considerations-for-therapeutic-cancer-vaccines-guidance-for-industry/e0e6e4e0-a883-4f71-bf37-784e147d32d9)
- [Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Donors of Whole Blood and Blood Components Intended for Transfusion:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/use-of-nucleic-acid-tests-to-reduce-the-risk-of-transmission-of-west-nile-virus-from-donors-of-whole-blood-and-blood-components-intended-for-transfusion-guidance-for-industry/863d535f-7224-46e2-84c2-785caa4abcf3)
- [Preclinical Assessment of Investigational Cellular and Gene Therapy Products:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/preclinical-assessment-of-investigational-cellular-and-gene-therapy-products-guidance-for-industry/e4aedc4e-81e3-4d2e-b655-2460ccf3a04e)